Biology Reference
In-Depth Information
90. Schmidt OI, Infanger M, Heyde CE, Ertel W, Stahel PF. The role of neuroinflammation
in traumatic brain injury. Eur J Trauma 2004;30:135-49.
91. Rothwell N. Interleukin-1 and neuronal injury: mechanisms, modification and therapeu-
tic potential. Brain Behav Immun 2003;17(3):152-57.
92. Gosselin D, Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress
on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav Immun
2007;21(3):281-89.
93. Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK. Experimental
brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res
Mol Brain Res 1995;30(1):125-30.
94. Fassbender K, Schneider S, Bertsch T, Schlueter D, Fatar M, Ragoschke A, et al.
Temporal profile of release of interleukin-1beta in neurotrauma. Neurosci Lett 2000;
284(3):135-38.
95. Lu K-T, Wang Y-W, Yang J-T, Yang Y-L, Chen H-I. Effect of interleukin-1 on traumatic
brain injury-induced damage to hippocampal neurons. J Neurotrauma 2005;22(8):885-95.
96. Toulmond S, Rothwell NJ. Interleukin-1 receptor antagonist inhibits neuronal damage
caused by fluid percussion injury in the rat. Brain Res 1995;671(2):261-66.
97. DeKosky ST, Styren SD, O'Malley ME, Goss JR, Kochanek P, Marion D, et al.
Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain.
Ann Neurol 1996;39(1):123-27.
98. Basu A, Krady JK, O'Malley M, Styren SD, DeKosky ST, Levison SW. The type 1
interleukin-1 receptor is essential for the efficient activation of microglia and the induc-
tion of multiple proinflammatory mediators in response to brain injury. J Neurosci
2002;22(14):6071-82.
99. Tehranian R, Andell-Jonsson S, Beni SM, Yatsiv I, Shohami E, Bartfai T, et al. Improved
recovery and delayed cytokine induction after closed head injury in mice with cen-
tral overexpression of the secreted isoform of the interleukin-1 receptor antagonist.
J Neurotrauma 2002;19(8):939-51.
100. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic
brain injury-mediated caspase-1 activation, tissue damage and neurological dysfunction.
Neurosurgery 2001;48:1393-99.
101. McClain CJ, Cohen D, Ott L, Dinarello CA, Young B. Ventricular fluid interleukin-1
activity in patients with head injury. J Lab Clin Med 1987;110(1):48-54.
102. Shimonkevitz R, Bar-Or D, Harris L, Dole K, McLaughlin L, Yukl R. Transient
monocyte release of interleukin-10 in response to traumatic brain injury. Shock
1999;12(1):10-16.
103. Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fuijita K, Mouri T, et al. Cerebrospinal
fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic
brain injury. Shock 2005;23(5):406-10.
104. Winter CD, Iannotti F, Pringle AK, Trikkas C, Clough GF, Church MK. A microdialysis
method for the recovery of IL-1beta, IL-6 and nerve growth factor from human brain
in vivo . J Neurosci Methods 2002;119(1):45-50.
105. Holmin S, Höjeberg B. In situ detection of intracerebral cytokine expression after human
brain contusion. Neurosci Lett 2004;369(2):108-14.
106. Hillman J, Aneman O, Persson M, Andersson C, Dabrosin C, MellergÄrd P. Variations
in the response of interleukins in neurosurgical intensive care patients monitored using
intracerebral microdialysis. J Neurosurg 2007;106(5):820-25.
Search WWH ::




Custom Search